Search clinical trials for: Dopamine D2 Receptor Antagonists

Total 10495 results

Janssen-Cilag International NV

Completed

An Efficacy, Safety And Tolerability Study of Flexibly Dosed Paliperidone Extended Release (ER) in Participants With Schizophrenia (PERFlexS)

Schizophrenia

France, United Kingdom, Belgium, Germany, Spain, Portugal, Bulgaria, Serbia, Switzerland, Israel, Finland, Greece, Sweden, Russian Federation, Netherlands, Denmark, Hungary, Lithuania, Latvia, Croatia, Turkey, Poland
Xian-Janssen Pharmaceutical Ltd.

Completed

A Study of Paliperidone Palmitate in Patients With Schizophrenia Previously Unsuccessfully Treated by Oral Antipsychotics

Schizophrenia

China
Chonbuk National University Hospital
Janssen Korea, Ltd., Korea

Completed

Efficacy and Safety of Paliperidone ER in First Episode Psychosis

First Episode Psychosis

Korea, Republic of
Janssen-Cilag International NV

Completed

Paliperidone Palmitate Flexible Dosing in Schizophrenia (PALMFlexS)

Schizophrenia

France, Ukraine, United Kingdom, Germany, Spain, Israel, Portugal, Turkey, Greece, Sweden, Belgium, Netherlands, Hungary, Denmark, Lithuania, Latvia, Croatia, Estonia, Austria, Switzerland
Johnson & Johnson Taiwan Ltd

Completed

Symptomatic Remission and Social Function in Participants Treated With Paliperidone Extended Release (ER)

Schizophrenia
Janssen-Cilag Pty Ltd

Completed

An Open Label Multicentre Study to Determine the Dose Distribution of Paliperidone ER in Patients With Schizophrenia

Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development...

Completed

As Study of the Pharmacokinetics of Paliperidone Extended-release and Risperidone Immediate-release Formulations

Schizophrenia | Schizoaffective Disorder
Johnson & Johnson Pharmaceutical Research & Development...

Completed

Efficacy and Safety of a Long Acting Anti-Psychotic Versus Placebo in Patients With Schizophrenia

Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Safety and Tolerability Study of Paliperidone Palmitate Injected in the Shoulder or the Buttock Muscle in Patients With Schizophrenia

Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of QT and QTc Intervals in Patients Administered Extended Release Paliperidone or Quetiapine

Schizophrenia | Schizoaffective Disorder
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Pharmacokinetic Study of the Relative Bioavailability of Paliperidone ER Formulations With Different Release Profiles and a Comparison to Paliperidone IR

Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Dose Proportionality of Extended Release Paliperidone

Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development...

Completed

Trial Evaluating Paliperidone Extended-Release (ER) Tablets Versus Placebo on Sleep in Schizophrenia Patients

Schizophrenia | Insomnia
National Institute of Mental Health (NIMH)

Completed

PET Imaging of Dopamine in Healthy Study Participants

Healthy

United States
National Heart, Lung, and Blood Institute (NHLBI)

Withdrawn

Metoclopramide to Treat Anemia in Patients With Myelodysplastic Syndrome (MDS)

Myelodysplastic Syndromes

United States
Seoul National University Hospital

Completed

The Effect of Paliperidone Palmitate in Schizophrenia (sustenna)

Schizophrenia

Korea, Republic of
Otsuka Pharmaceutical Development & Commercialization...
H. Lundbeck A/S

Completed

Trial to Evaluate the Short-term Safety & Efficacy of Brexpiprazole Monotherapy in the Treatment of Adolescents With Schizophrenia

Schizophrenia

United States
University of Texas Southwestern Medical Center

Completed

Aripiprazole for Bipolar Disorder and Alcohol Use Disorder

Alcoholism | Bipolar Disorder | Alcohol Abuse

United States
Shanghai Mental Health Center

Withdrawn

Acceptance and Commitment Therapy in SSRI-Resistant Obsessive Compulsive Disorder

Obsessive-Compulsive Disorder
Otsuka Beijing Research Institute

Completed

Safety and Efficacy of Brexpiprazole in the Treatment of Schizophrenia

Schizophrenia

China
Otsuka Pharmaceutical Development & Commercialization...
H. Lundbeck A/S

Completed

Efficacy, Safety, and Tolerability of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Bipolar I Patients

Bipolar I Disorder

United States, Taiwan, Romania, Korea, Republic of, Japan, Poland, Canada
Otsuka Pharmaceutical Development & Commercialization...

Completed

Open-label Study to Assess Usability of the Medical Information Device #1 (MIND1) System in Adults With Schizophrenia On Oral Aripiprazole

Nervous System Diseases | Schizophrenia | Mental Disorder

United States
H. Lundbeck A/S
Otsuka Pharmaceutical Co., Ltd.

Completed

Aripiprazole Once-monthly in Patients With Schizophrenia

Schizophrenia

United States
CMG Pharmaceutical Co. Ltd

Completed

Comparative Bioavailability Study of Aripiprazole 10 mg Oral Soluble Film vs Abilify® 10 mg Tablet in Healthy Volunteers

Schizophrenia
US Department of Veterans Affairs

Withdrawn

Aripiprazole for Methamphetamine Dependence: Double Blind Placebo Trial

Methamphetamine Dependence
Wei Hao

Terminated

An Study of Aripiprazole in the Treatment of Methamphetamine Dependence

Methamphetamine Dependence

China
Otsuka Pharmaceutical Development & Commercialization...
Covance

Completed

Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia (ASPIRE)

Schizophrenia

Spain, Korea, Republic of, United States, Russian Federation, Chile, Estonia, Finland, Mexico, Hungary, Bulgaria, Croatia, Serbia, France, Poland, Romania, Thailand, Puerto Rico, Slovakia, Taiwan, Australia, India, Argentina, South... and more
Duke University
Bristol-Myers Squibb

Completed

Metabolic Signatures and Biomarkers in Schizophrenia

Schizophrenia

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

A Multiple Dose Safety, Tolerability and Pharmacokinetics Study in Adult Patients With Schizophrenia Following Administration of Aripiprazole IM Depot

Schizophrenia

United States
North Suffolk Mental Health Association
Eli Lilly and Company

Completed

A Placebo-Controlled, Cross-Over Trial of Aripiprazole

Schizophrenia

United States
Johnson & Johnson Pharmaceutical Research & Development...
Janssen, LP

Completed

Evaluation of Effectiveness of Risperdal® Consta® Compared to Abilify® Over a Two-year Period in Patients With Schizophrenia

Psychotic Disorders | Schizophrenia
Taichung Veterans General Hospital

Unknown

Heart Rate Changes in Schizophrenic and Bipolar Patients Under the Medication of Aripiprazole and Quetiapine (HeartAriQue)

Schizophrenia | Bipolar

Taiwan
Vanderbilt University Medical Center

Recruiting

Pragmatic Trial Comparing Weight Gain in Children With Autism Taking Risperidone Versus Aripiprazole

Autism Spectrum Disorder | Weight Gain | Medication Side Effect

United States
Northwell Health
National Institutes of Health (NIH)

Completed

Striatal Connectivity and Clinical Outcome in Psychosis

Psychotic Disorders

United States
Genuine Research Center, Egypt
P&C Labs, Egypt

Completed

Bioequivalence Study of Aripiprazole From Apipe 10 mg Orally Disintegrating Tablets (Man. by: P&C Labs (Pellets & CR Products), Egypt) Versus Abilify 10 mg Orodispersible Tablets (Otsuka Pharmaceutical Netherlands B.V., Netherlands)

Healthy

Egypt
Martha Sajatovic
Otsuka Pharmaceutical Development & Commercialization, Inc.

Completed

CAE Plus LAI in Individuals With Bipolar Disorder at Risk for Treatment Non-adherence (BD-CAEL)

Bipolar Disorder | Medication Adherence | Medication Non Adherence

United States
Children's Hospital of Fudan University

Withdrawn

Clinical Efficacy and Change of Life Quality Through Using the Comprehensive Behavioral Intervention Treatment for Tics

Tic Disorders
Alkermes, Inc.

Completed

A Study of Aripiprazole Lauroxil (Also Known as ARISTADA TM) in Subjects With Schizophrenia

Schizophrenia

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (ARRIVE US)

Schizophrenia

United States, Canada
Serge Beaulieu
Bristol-Myers Squibb

Terminated

Low-Dose Adjunctive Aripiprazole in the Treatment of Bipolar Depression: Double-Blind Placebo-Controlled Pilot Study

Bipolar Disorder | Depressive Episode

Canada
San Francisco Department of Public Health
National Institute on Drug Abuse (NIDA)

Completed

Aripiprazole Treatment for Methamphetamine Dependence Among High-risk Individuals

HIV Infections | Substance Abuse

United States
Bristol-Myers Squibb
Otsuka America Pharmaceutical

Completed

A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder

Major Depressive Disorder

United States
Janssen Research & Development, LLC

Completed

An Efficacy and Safety Study of Extended-Release (ER) Paliperidone in Adolescent Participants With Schizophrenia

Schizophrenia

Ukraine, United States, Spain, India, Romania, Russian Federation, Slovakia
Si Tianmei

Unknown

A Multicenter Study to Evaluate the Effects of Switching to Aripiprazole 12 Weeks on the Sexual Dysfunction From Risperidone or Paliperidone in Patients With Schizophrenia Spectrum Disorders or Bipolar Spectrum Disorders

Sexual Dysfunction | Hyperprolactinemia

China
Universita di Verona

Unknown

Randomized Evaluation of the Effectiveness of Clozapine and Aripiprazole Versus Clozapine and Haloperidol in the Treatment of Schizophrenia (CHAT)

Schizophrenia

Italy
Seoul National University Hospital
Korea Otsuka Pharmaceutical Co., Ltd.

Completed

Aripiprazole Augmentation for Clozapine-Treated Patients With Refractory Schizophrenia

Schizophrenia

Korea, Republic of
Duke University
The Emmes Company, LLC

Completed

Long-term Antipsychotic Pediatric Safety Trial (LAPS)

Weight, Body

United States
Otsuka Pharmaceutical Co., Ltd.

Active, not recruiting

Specified Drug-use Survey on Abilify Prolonged Release Aqueous Suspension for IM Injection (Prevention of Relapse of Mood Episodes in BP)

Bipolar Disorder I

Japan
Peking University

Completed

Pharmacologic Treatment of Acute Episode of Schizophrenia: a Real World Study

Acute Schizophrenia Episode

China
New York State Psychiatric Institute
Bristol-Myers Squibb; National Institute of Mental Health (NIMH); Otsuka Pharmaceutical...

Terminated

Treatment of Children With ADHD Who do Not Fully Respond to Stimulants (TREAT)

Attention Deficit Hyperactivity Disorder

United States

Search clinical trials for: Dopamine D2 Receptor Antagonists

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Japan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations